Close Menu

    Subscribe to Updates

    Get the latest information from JBUON.

    What's Hot

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025
    Facebook X (Twitter) Instagram
    JBUONJBUON
    • How to Submit
    • Author Guidelines
    Facebook X (Twitter) Instagram
    SUBMIT
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Archives
    • About Journal
      • Journal Information
      • Editorial Board
      • Bibliographic Listings
      • Editorial Policy
      • Ethics and Malpractice Statement
    • For Authors
      • How To Submit
      • Submit Article
      • Downloads
    • Contact
    JBUONJBUON
    Home»Issues»Volume 26, Issue 6»Super enhancer-associated CCAT1 lncRNA promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in gastric cancer
    Volume 26, Issue 6

    Super enhancer-associated CCAT1 lncRNA promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in gastric cancer

    December 1, 2021Updated:April 29, 20242 Mins Read
    Share
    Facebook Twitter Email

    Lingzhi Peng1*, Tianxiang Liu1*, Chenglou Zhu2*, Chongya Yang3, Qiong Wang4, Mingxu Da1,2

    1Department of Surgical Oncology, Gansu Provincial Hospital, Lanzhou, 730000, China.

    2First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, China.

    3Department of Geriatrics, Lintao County Hospital of Chinese Medicine, Dingxi, 730500, China.

    4Department of Internal Medicine, Second People’s Hospital of Jiuquan City, Jiuquan, 735000, China.

    *These authors contributed equally to this work.

    Summary

    Purpose: Long non-coding RNAs (lncRNAs) promote gastric cancer invasion and metastasis via epithelial-to-mesenchymal transition (EMT). Super enhancers (SEs) regulate the expression of key oncogenic lncRNAs. Here, we attempted to identify EMT-regulating SE-associated lncRNAs.

    Methods: H3K27ac histone acetylation was used as an SE marker, and chromatin immunoprecipitation sequencing (ChIP-seq) was performed to compare the SE landscape in SGC-7901 gastric adenocarcinoma and GES-1 in non-cancer gastric mucosa cell lines. Cancer associated transcript-1 (CCAT1) was knocked down in MKN-45 gastric adenocarcinoma cells and overexpressed in SGC-7901 cells. CCAT1 was detected by real-time PCR in GES-1, SGC-7901, and MKN-45 cells. Cell proliferation, migration and invasion were analyzed by Cell Counting kit-8, wound healing, and transwell assays, respectively. E-cadherin and N-cadherin expression was evaluated by western blotting.

    Results: We identified 838 SEs in SGC-7901 and 206 SEs in GES-1 cells. SE-associated CCAT1 was identified as an EMT-related lncRNA upregulated in SGC-7901 and MKN45 cells. Analysis of the Cancer Cell Line Encyclopedia and The Cancer Genome Atlas revealed elevated CCAT1 expression in various tumor cells and tissues. CCAT1 expression was associated with high cell proliferation, invasion, and migration and correlated negatively with E-cadherin, but positively with N-cadherin levels.

    Conclusions: CCAT1 is upregulated in gastric cancer cells. CCAT1 is an EMT-promoting and SE-associated lncRNA that promotes cell proliferation, invasion, and migration. Therefore, CCAT1 may represent a potential diagnostic and therapeutic target for gastric cancer.

    Key words: colon cancer associated transcript-1, epithelial-to-mesenchymal transition, gastric cancer, long non-coding RNA, super enhancer.

    Full Text: PDF

    Original Article
    Previous ArticleAnalysis on safety and efficacy of low-dose apatinib combined with paclitaxel as second-line treatment for advanced gastric cancer
    Next Article PLA2G3 phospholipase expression patterns in colon adenocarcinoma

    Related Articles

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    Volume 27, 2024

    Malignant Diseases as a Reason for Interventions by Emergency Medical Teams in Barajevo 2023

    Volume 27, 2024

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    Volume 26, Issue 6
    Don't Miss
    Volume 27, 2024

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Dimosthenis Chrysikos1, Spiros Delis2, Charina Triantopoulou2, Evgenia Charitaki2, Nikos Kokoroskos2, Nikolaos Taprantzis1*, Amir Shihada1, Konstantinos…

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025

    Abdominal Aortic Aneurysm and Radiation Therapy

    October 28, 2024
    Our Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021

    Subscribe to Updates

    About Us
    About Us

    Journal of BUON (Print ISSN: 1107-0625, Electronic ISSN: 2241-6293) is an independent Open Access Journal, published by BAKIS Productions LTD, and appears exclusively on the internet. It is covered/indexed in Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica.
    We're accepting new manuscripts right now.

    Email Us: editorial_office@jbuon.com
    Contact: Available soon

    Editorial Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021
    Get in Touch

    Editor-in-Chief
    Athanasios E. Athanasiou,
    Department of Medical Oncology,
    Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece
    Editorial Office: editorial_office@jbuon.com

    Publishing support
    EManuscript Technologies
    # 9, First Floor, Vinnse Towers
    Wheeler Road Extension, St. Thomas Town, Bangalore 560 084, INDIA
    E: journals@emanuscript.in 
    W : www.emanuscript.in

     

    • Home
    • Author Guidelines
    • Site Map
    • Contact Us
    © 2025 JBUON Powered by EManuscript.

    Type above and press Enter to search. Press Esc to cancel.